TSAO Compounds: The Comprehensive Story of a Unique Family of HIV- 1 Specific Inhibitors of Reverse Transcriptase

E-ISSN： 1873-4294|4|9|945-963

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.4, Iss.9, 2004-05, pp. : 945-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TSAO Derivatives, Inhibitors of HIV-1 Reverse Transcriptase Dimerization: Recent Progress

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1895-1907

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the DABOs Family as Potent HIV-1 non-Nucleoside Reverse Transcriptase Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2376-2385

Bentham Science Publishers

Access to resources Recommend Favorite